Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine serous papillary carcinoma cell lines in vitro
Bellone, Stefania, Black, Jonathan, English, Diana P., Schwab, Carlton L., Lopez, Salvatore, Cocco, Emiliano, Bonazzoli, Elena, Predolini, Federica, Ferrari, Francesca, Ratner, Elena, Silasi, Dan-ArinVolume:
214
Language:
english
Journal:
American Journal of Obstetrics and Gynecology
DOI:
10.1016/j.ajog.2015.08.011
Date:
January, 2016
File:
PDF, 776 KB
english, 2016